Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
Wen-Huan FengTingting YinXuehui ChuXiaodong ShanCan JiangYan WangYufen QianDalong ZhuXitai SunYan BiPublished in: Diabetes/metabolism research and reviews (2019)
For obese Chinese patients with T2DM, RYGB resulted in better metabolic control, greater weight loss, and lower medication usage and NAFLD, but more frequently resulted in diseases related to nutrient deficiency.
Keyphrases
- roux en y gastric bypass
- weight loss
- bariatric surgery
- gastric bypass
- obese patients
- glycemic control
- minimally invasive
- healthcare
- coronary artery bypass
- weight gain
- type diabetes
- adipose tissue
- surgical site infection
- physical activity
- emergency department
- percutaneous coronary intervention
- insulin resistance
- drug induced
- smoking cessation